Bristol Myers Squibb (BMY) Cash & Equivalents (2009 - 2026)
Bristol Myers Squibb's Cash & Equivalents came in at $8.72 billion for Q2 2026, down 30.8% from $12.6 billion a year earlier and down 8.9% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb's Cash & Equivalents was $10.21 billion, down 1.3% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $10.35 billion in FY2024 (-9.8%), $11.46 billion in FY2023 (+25.7%), $9.12 billion in FY2022 (-34.7%) and $13.98 billion in FY2021 (-3.9%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q3 2024.
- Year-over-year, Cash & Equivalents has declined for three consecutive quarters, with growth averaging 20.9% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2025 (growth of 100.2%), and the weakest in Q3 2022 (a decline of 42.9%).
- Business Quant data shows BMY's Cash & Equivalents at $9.57 billion (Q1 2026), $10.21 billion (Q4 2025) and $15.73 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Bristol Myers Squibb | 125.59 Bn | 76.86 Bn | 9.25 Bn | 8.72 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.72 Bn |
| Mar 31, 2026 | 9.57 Bn |
| Dec 31, 2025 | 10.21 Bn |
| Sep 30, 2025 | 15.73 Bn |
| Jun 30, 2025 | 12.60 Bn |
| Mar 31, 2025 | 10.88 Bn |
| Dec 31, 2024 | 10.35 Bn |
| Sep 30, 2024 | 7.89 Bn |
| Jun 30, 2024 | 6.29 Bn |
| Mar 31, 2024 | 9.33 Bn |
| Dec 31, 2023 | 11.46 Bn |
| Sep 30, 2023 | 7.51 Bn |
| Jun 30, 2023 | 8.37 Bn |
| Mar 31, 2023 | 9.00 Bn |
| Dec 31, 2022 | 9.12 Bn |
| Sep 30, 2022 | 7.73 Bn |
| Jun 30, 2022 | 10.75 Bn |
| Mar 31, 2022 | 12.37 Bn |
| Dec 31, 2021 | 13.98 Bn |
| Sep 30, 2021 | 13.54 Bn |
API Access
Bristol Myers Squibb Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();